DBP and myeloid sarcoma: Interestingly, the only patient diagnosed with somatophorm disorder was classified as an outlier in the clusterization concerning DBP isoforms (Fig 4B) and she was included in the subset of patients suffering from less aggressive MS when ApoE and DBP isoforms were considered together (Fig 5A, Table 5).